Tag: drugmakers

Revenue earnings for drugmakers will remain limited in Sub-Saharan Africa (SSA) despite lax pricing rules due to high out-of-pocket (OOP) spending in SSA, which raises questions about affordability, according to ...

Nigeria’s pharmaceutical industry is likely to continue facing broad-based challenges, including a weak business environment that threatens to heighten the sector’s risks to declining investment, according to Fitch Solutions. Nigeria ...